Navigation Links
NeurogesX to Present at Two February Investor Conferences
Date:2/8/2011

any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to: statements regarding the potential benefits of the new director appointee to the NeurogesX Board of Directors; and the potential submission to the U.S. Food and Drug Administration of a supplemental new drug application for label expansion of Qutenza.  Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the commercialization of Qutenza, including with respect to manufacture and supply of Qutenza; unexpected adverse side effects of Qutenza; physician or patient reluctance to use Qutenza, despite the Company's efforts and strategies to commercialize Qutenza; and difficulties or delays in the further development of Qutenza and efforts towards label expansion; and potential competitors and competitive products. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX, Inc.Stephen Ghiglieri

Chief Financial Officer

(650) 358-3310The Ruth GroupSara Pellegrino (investors)

(646) 536-7002

spellegrino@theruthgroup.comJason Rando (media)

(646) 536-7025

jrando@theruthgroup.com
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... IRIDEX Corporation (NASDAQ: IRIX ) today ... is scheduled to make an investor presentation at the Robert ... Time on Wednesday, September 3, in New York City.  ... will be available in the Investors section of the IRIDEX ... IRIDEX Corporation was founded in 1989 and is ...
(Date:8/27/2014)... , Aug. 27, 2014   Auxilium Pharmaceuticals , Inc. ... biopharmaceutical company, today announced that certain members of the ... Healthcare Conference to be held September 8-10, 2014 in ... , Chief Executive Officer and President, is scheduled to ... portfolio at 10:55 a.m. ET on Wednesday, September 10, ...
(Date:8/27/2014)... PARK, Calif. , Aug. 27, 2014 ... the U.S. Food and Drug Administration (FDA) to initiate ... in patients with complete cervical spinal cord injury.  The ... 1 clinical study of the product, and is designed ... AST-OPC1 in patients with complete cervical spinal cord injuries, ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5
... Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is ... Sodium, USP, 3 mg Tablets to include additional products ... May 17, 2010 and November 17, 2010.  The company ... a single bottle labeled as Jantoven® Warfarin Sodium, USP, ...
... Feb. 18, 2011 PreXion, Inc., ( www.prexion.com ... Beam Computed Tomography (CBCT) Imaging systems for dentistry, ... shipping a new 3D cone beam imaging product, ... new system incorporates PreXion,s proprietary CLEARimage™ technology that ...
Cached Medicine Technology:Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System 2PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System 3
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first ... Digital O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... rooms will be Buzz, a centralized surgical hub for ... planning, navigation, imaging and communications connectivity. , Buzz ... and hardware all controlled from the full HD 42” ...
(Date:8/27/2014)... SCOTT Sports is excited to announce ... mountain bike and BMX park. SCOTT will provide Wasatch ... adult and youth sizes for the park’s rental bike program. ... in Ogden, Utah, recently moved its U.S. headquarters from Sun ... to be a partner with the Wasatch Bike Park, what ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. ... the need for blood transfusions might also protect the brains ... (EPO), which stimulates red blood cell production, appears to prevent ... researcher Dr. Petra Huppi, a professor of pediatrics and newborn ... real test of whether EPO protects the brains of these ...
(Date:8/27/2014)... Centre into Microtechnologies, is coordinating the microSCALE ... based on microtechnologies to tackle the problems ... among others. IK4-Ikerlan, Ceit-IK4, IK4-Tekniker, the Mondragon ... microGUNE on this project, which is being ... programme of the Government of the Basque ...
(Date:8/27/2014)... water and oil and are persistent towards aggressive ... characteristics have made the fluorochemicals useful in numerous ... paper and board. , The problem with fluorochemicals ... and accumulate in both humans and the environment. ... effects, such as cancer, increased cholesterol and a ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Microtechnologies for driving forward mobility and human health 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3
... violence often accompanied by attempts to get young women pregnant ... says that male partners of teenage girls and young women ... to sabotage the birth control the women are using. , ... Contraception , also finds that women who experience both ...
... , PITTSBURGH , Jan. 25 ... for serious athletes, and now the company is throwing its brand ... who know how to push the limits:  Dick,s Sporting Goods ... and energy products and other nutritional supplements is now the presenting ...
... ... ... (FEIN #,s 84-1402*** & 80-0510***, CO Charity #20093014664) is calling on all Cannabis Churches ... issues. "Shamans, Doctors, and Spiritual Leaders have been in charge of healing all the worlds ...
... ... of leading B2B online comparison shopping marketplaces, today announced that it now has the ... can now streamline medical supply procurement by using the www.med32.com multivendor comparison-shopping ... ...
... Young women and teenage girls often face efforts ... pregnancy including damaging condoms and destroying contraceptives ... associated with physical or sexual violence, a study by ... found. Published online today in the January issue ...
... , ... Rehabiltation Services for children (BHRS/Wraparound) offered from the Christian perspective, promote faith-formation. , ... (PRWEB) January 24, 2010 ... teamed up with Parakleseos, LLC, a Christian-based behavioral health practice in Beaver, PA in ...
Cached Medicine News:Health News:Male Abusers Often Sabotage Birth Control With Partners 2Health News:GNC Becomes a Presenting Sponsor for the Pittsburgh Health & Fitness Expo of the Dick's Sporting Goods Pittsburgh Marathon 2Health News:GNC Becomes a Presenting Sponsor for the Pittsburgh Health & Fitness Expo of the Dick's Sporting Goods Pittsburgh Marathon 3Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 2Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 3Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 4Health News:Online Medical Supply Comparison Shopping Service Saves Nursing Homes Money 2Health News:Reproductive coercion often is accompanied by physical or sexual violence, study finds 2Health News:Reproductive coercion often is accompanied by physical or sexual violence, study finds 3Health News:Christian Nonprofit and Behavioral Health Practice Team Up to Help Children 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: